These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9189053)

  • 1. The effect of sulphasalazine on neutrophil superoxide generation in rheumatoid arthritis.
    Bradley SM; le Gallez P; Throughton PR; Gooi HC; Astbury C; Bird HA
    Br J Rheumatol; 1997 May; 36(5):530-4. PubMed ID: 9189053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sulphasalazine and sulphapyridine on neutrophil superoxide production: role of cytosolic free calcium.
    Kanerud L; Hafström I; Ringertz B
    Ann Rheum Dis; 1990 May; 49(5):296-300. PubMed ID: 1971506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methotrexate, sulphasalazine and aurothiomalate on polymorphonuclear leucocytes in rheumatoid arthritis.
    Storgaard M; Jensen MP; Stengaard-Pedersen K; Møller BK; Anderson PL; Obel N
    Scand J Rheumatol; 1996; 25(3):168-73. PubMed ID: 8668961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which component of sulphasalazine is active in rheumatoid arthritis?
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1985 May; 290(6481):1535-8. PubMed ID: 2860942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
    Taggart AJ; Neumann VC; Hill J; Astbury C; Le Gallez P; Dixon JS
    Drugs; 1986; 32 Suppl 1():27-34. PubMed ID: 2877851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of neutrophil function by plasma of rheumatoid arthritis patients treated with infliximab.
    Dain L; Braun-Moscovici Y; Baum E; Nahir AM; Hoffer E
    Clin Exp Rheumatol; 2006; 24(1):38-44. PubMed ID: 16539817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sulphasalazine and its metabolites on neutrophil chemotaxis, superoxide production, degranulation and translocation of cytochrome b-245.
    Wandall JH
    Aliment Pharmacol Ther; 1991 Dec; 5(6):609-19. PubMed ID: 1685923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
    Bird HA
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of sulphasalazine--a review.
    Capell HA
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():35-9. PubMed ID: 8535647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of sulphasalazine, sulphapyridine, 5-aminosalicylic acid and prednisolone on superoxide production by human polymorphonuclear leukocytes: in vitro studies].
    Ide T
    Nihon Shokakibyo Gakkai Zasshi; 1986 Sep; 83(9):2090. PubMed ID: 3025481
    [No Abstract]   [Full Text] [Related]  

  • 11. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
    Neumann VC; Taggart AJ; Le Gallez P; Astbury C; Hill J; Bird HA
    J Rheumatol; 1986 Apr; 13(2):285-7. PubMed ID: 2873245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components.
    Dougados M; Combe B; Cantagrel A; Goupille P; Olive P; Schattenkirchner M; Meusser S; Paimela L; Rau R; Zeidler H; Leirisalo-Repo M; Peldan K
    Ann Rheum Dis; 1999 Apr; 58(4):220-5. PubMed ID: 10364900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphasalazine: mechanism of action in rheumatoid arthritis.
    Smedegård G; Björk J
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():7-15. PubMed ID: 8535652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Comparison with 5-aminosalicylic acid, sulfapyridine and olsalazine.
    Neal TM; Winterbourn CC; Vissers MC
    Biochem Pharmacol; 1987 Sep; 36(17):2765-8. PubMed ID: 2888463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
    Miyachi Y; Yoshioka A; Imamura S; Niwa Y
    Gut; 1987 Feb; 28(2):190-5. PubMed ID: 2881849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphasalazine in the treatment of rheumatoid arthritis.
    Box SA; Pullar T
    Br J Rheumatol; 1997 Mar; 36(3):382-6. PubMed ID: 9133974
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulphasalazine in rheumatoid arthritis: pointers to a gut-mediated immune effect.
    Sheldon PJ; Webb C; Grindulis KA
    Br J Rheumatol; 1987 Aug; 26(4):318-9. PubMed ID: 2886178
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative study of the effects of bucillamine and salazosulfapyridine in the treatment of rheumatoid arthritis.
    Nakajima M; Ueda N; Ohara H; Abe M; Kinoshita M
    Mod Rheumatol; 2009; 19(4):384-9. PubMed ID: 19363607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of enhanced superoxide generation by neutrophils with low superoxide scavenging activity of the peripheral blood, joint fluid, and their leukocyte components in rheumatoid arthritis: effects of slow-acting anti-rheumatic drugs and disease activity.
    Prónai L; Ichikawa Y; Ichimori K; Nakazawa H; Arimori S
    Clin Exp Rheumatol; 1991; 9(2):149-55. PubMed ID: 1647912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro immunomodulatory effects of sulfasalazine and its metabolites.
    Comer SS; Jasin HE
    J Rheumatol; 1988 Apr; 15(4):580-6. PubMed ID: 2899646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.